Vertex Pharmaceuticals News and Activities

Presence

Vertex Pharmaceuticals develops medicines for serious diseases. Its main products include specialty therapies and genetic medicine programs for patients, healthcare providers, and health systems, with a strong focus on rare and chronic conditions.

Vertex Pharmaceuticals products and services overview:

Specialty medicines
Genetic therapies
Cell therapies
Research services
Rare disease treatments

Revenue: ~$11 billion

Employees: 6,200

Headquarters: Boston, United States (USA)

Vertex Pharmaceuticals is one of the...

Vertex Pharmaceuticals is a company listed under the stock ticker VRTX (US).

Vertex Pharmaceuticals has a direct presence in 2 countries.

They are in:

Biotechnology67%
Pharmaceuticals33%

Executives

View the org chart displaying its 63 main executives

Most searched biographies at Vertex Pharmaceuticals

Popular executive movements at Vertex Pharmaceuticals

Taylor Uttley who was Senior Director and Head of Strategy and Operations, Data Strategy and Solutions, becomes Senior Director, Head of Digitization Strategy Center of Excellence (posted on April 30 2026).
Suketu Upadhyay, Director, has left the company (posted on April 30 2026).
Stacey Dillon, Vice President, Research, has left the company (posted on April 30 2026).

Click here to view some more movements at Vertex Pharmaceuticals

Create your alert
to follow the executive moves at Vertex Pharmaceuticals.